EcoDrugPlus

Aurora Kinase C-Like

Ensembl ID : ENSCMIG00000011464
Gene Symbol: LOC103190377
4 Cross references
206 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCMIG00000007435
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCMIG00000010257
Gene Symbol: BDKRB2
4 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSCMIG00000018903
Gene Symbol: BCHE
1 Cross references
131 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSCMIG00000014961
Gene Symbol: CALCRL
3 Cross references
134 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 2a

Ensembl ID : ENSCMIG00000011755
Gene Symbol: CACNG2A
1 Cross references
262 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSCMIG00000003823
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSCMIG00000015429
Gene Symbol: CACNA2D1
3 Cross references
304 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSCMIG00000000661
Gene Symbol: CACNA2D2
3 Cross references
280 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSCMIG00000004505
Gene Symbol: CACNA2D3
3 Cross references
223 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSCMIG00000019715
Gene Symbol: CACNA2D4
3 Cross references
318 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1

Ensembl ID : ENSCMIG00000017445
Gene Symbol: CACNB1
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).